Table 2 Blood lipid profile of various groups after 12Â weeks of study duration
Parameters | ||||||||
|---|---|---|---|---|---|---|---|---|
GROUP | TC value (mg dl−1) ± SEM | LDL-C value (mg dl−1) ± SEM | HDL-C value (mg dl−1) ± SEM | TG value (mg dl−1) ± SEM | VLDL-C (mg dl−1) Value ± SEM | LDL/HDL ratio ± SEM | Atherogenic index ± SEM | |
1 | Blank Control | 105 ± 5.013 | 58.75 ± 18.25 | 30.65 ± 1.74 | 78 ± 3.527 | 35.45 ± 3.074 | 1.917 ± 0.56 | 0.406 ± 0.037 |
2 | Disease Control | 946 ± 38.53 | 848.8 ± 34.19 | 27.83 ± 0.82 | 347 ± 10.04 | 157.7 ± 2.29 | 30.50 ± 0.69 | 1.096 ± 0.040 |
3 | Atorvastatin | *** 625 ± 17.42 | *** 539.65 ± 15.01 | *** 37.35 ± 1.72 | *** 240 ± 5.49 | *** 109.1 ± 3.35 | *** 14.45 ± 0.99 | *** 0.808 ± 0.061 |
4 | Proanthocyanidins (OPC) | *** 733 ± 21.42 | *** 647.8 ± 19.34 | ns 33.24 ± 2.09 | *** 260 ± 9.10 | *** 118.2 ± 2.09 | *** 19.49 ± 0.87 | ** 0.893 ± 0.033 |
5 | Nicotinic acid (NA) | ** 806 ± 16.51 | ** 715.1 ± 19.87 | * 35.29 ± 1.85 | ** 278 ± 8.66 | ** 126.4 ± 4.79 | *** 20.26 ± 0.94 | ** 0.896 ± 0.053 |
6 | Pterostilbene (PT) | *** 698 ± 14.19 | *** 607.16 ± 14.45 | ns 31.64 ± 3.03 | * 296 ± 3.64 | * 134.5 ± 6.30 | *** 19.19 ± 0.91 | * 0.971 ± 0.073 |
7 | OPC : NA (30:70) | *** 725 ± 15.92 | *** 635.1 ± 14.62 | *** 37.86 ± 1.88 | *** 260 ± 6.26 | *** 118.2 ± 3.93 | *** 16.77 ± 0.69 | *** 0.837 ± 0.045 |
8 | OPC : NA (50:50) | *** 704 ± 13.15 | *** 614.0 ± 12.58 | * 35.42 ± 1.36 | *** 273 ± 8.68 | ** 124.1 ± 3.76 | *** 17.33 ± 0.75 | ** 0.887 ± 0.037 |
9 | OPC : NA (70:30) | *** 642 ± 13.31 | *** 555.4 ± 11.65 | * 36.16 ± 2.13 | *** 252 ± 8.54 | *** 114.5 ± 3.38 | *** 15.36 ± 0.98 | *** 0.843 ± 0.041 |
10 | OPC : PT (30:70) | *** 598 ± 14.01 | *** 507.8 ± 10.38 | ns 33.42 ± 1.68 | ** 284 ± 3.81 | * 129.1 ± 4.17 | *** 15.19 ± 0.42 | * 0.929 ± 0.057 |
11 | OPC : PT (50:50) | *** 642 ± 15.60 | *** 553.5 ± 14.66 | ns 33.89 ± 2.12 | *** 273 ± 8.68 | ** 124.1 ± 3.76 | *** 16.33 ± 0.75 | ** 0.906 ± 0.037 |
12 | OPC : PT (70:30) | *** 608 ± 15.06 | *** 518.0 ± 12.37 | * 35.47 ± 2.16 | *** 252 ± 8.95 | *** 114.5 ± 3.38 | *** 14.60 ± 0.98 | ** 0.851 ± 0.041 |
13 | NA : PT (30:70) | *** 615 ± 15.02 | *** 526.2 ± 9.57 | ns 33.41 ± 1.61 | *** 277 ± 11.1 | ** 125.9 ± 3.04 | *** 15.75 ± 0.53 | * 0.919 ± 0.037 |
14 | NA : PT (50:50) | *** 646 ± 13.97 | *** 555.4 ± 12.30 | ** 36.63 ± 1.54 | *** 270 ± 7.07 | ** 122.7 ± 4.34 | *** 15.16 ± 0.84 | ** 0.868 ± 0.037 |
15 | NA : PT (70:30) | *** 659 ± 13.11 | *** 567.6 ± 10.70 | ** 37.44 ± 2.26 | *** 270 ± 5.91 | ** 122.7 ± 3.86 | *** 15.16 ± 0.89 | *** 0.858 ± 0.053 |
16 | OPC : NA : PT (50:30:20) | *** 563 ± 13.31 | *** 474.2 ± 11.55 | *** 38.20 ± 1.89 | *** 253 ± 6.65 | *** 115.0 ± 3.04 | *** 12.41 ± 0.72 | *** 0.821 ± 0.041 |
17 | OPC : NA : PT (50:20:30) | *** 572 ± 13.15 | *** 482.67 ± 8.29 | ** 37.53 ± 1.34 | *** 259 ± 9.46 | ** 120.5 ± 5.08 | *** 12.86 ± 0.78 | *** 0.839 ± 0.037 |
18 | OPC : NA : PT (20:50:30) | *** 588 ± 11.73 | *** 497.32 ± 13.06 | *** 38.68 ± 2.37 | *** 260 ± 2.81 | *** 118.2 ± 2.83 | *** 12.86 ± 1.17 | ** 0.827 ± 0.029 |